ImCheck Therapeutics vs Regis Technologies

ImCheck Therapeutics vs Regis Technologies, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImCheck Therapeutics is on 60/100 and Regis Technologies on Not scored yet.

ImCheck Therapeutics logo
ImCheck TherapeuticsImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.
Try ImCheck Therapeutics
Regis TechnologiesCDMO providing process development, analytical services, and cGMP API manufacturing for drug candidates.
Try Regis Technologies

Where each one leads

ImCheck Therapeutics

  • agent readiness: 34/100 against 24/100
  • domain rating: 38/100 against 0/100

Regis Technologies

Leads on none of the measures we hold for both companies.

At a glance

MeasureImCheck TherapeuticsRegis Technologies
What it isImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.CDMO providing process development, analytical services, and cGMP API manufacturing for drug candidates.
CategoryBiotech, MedTech, HealthTech, Drug DiscoveryBiotech, MedTech, Drug Discovery, Clinical Trials
Sells toBusiness modelB2BB2B
OfferingBiotechServices
Founded20151956
HeadquartersMarseille, FranceMorton Grove, United States
StatusActiveActive

Size, funding and growth

MeasureImCheck TherapeuticsRegis Technologies
Employees47Not published
Total funding$164MNot published
LinkedIn followers11,647Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureImCheck TherapeuticsRegis Technologies
StartupHub scoreOur 0-100 rating60/100Not published
Traction57/100Not published
Team70/100Not published
Community15/100Not published
Search visibility22/100Not published
Quality68/100Not published
Agent readinessHow well an AI agent can read and act on the siteF (34/100)F (24/100)
Domain ratingLink authority, 0-10038/1000/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureImCheck TherapeuticsRegis Technologies
HostingSelf ManagedNot detected
CDNNot detectedCloudflare
FrameworksJquery, Tailwind CSS, BootstrapTailwind CSS
AnalyticsGoogle Analytics 4Not detected

ImCheck Therapeutics vs Regis Technologies: common questions

Which is better, ImCheck Therapeutics or Regis Technologies?

On our 0-100 score ImCheck Therapeutics rates higher (60/100 against Not scored yet). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.

How do ImCheck Therapeutics and Regis Technologies compare on the numbers?

ImCheck Therapeutics leads on agent readiness (34/100 against 24/100), domain rating (38/100 against 0/100).

Read the full ImCheck Therapeutics review and pricing or the Regis Technologies review and pricing. You can also browse other ImCheck Therapeutics alternatives we track.